Welt is a startup that develops personalized digital therapeutics and wearables. Since spin-off from Samsung Electronics in 2016, it has entered the US and Japan, and is growing explosively more than four times a year. It is also growing by attracting more than 14 billion cumulative investments. Welt is actively promoting the development of Digital Therapeutics (DTx) / Digital Biomarker as part of its main business. We plan to develop DTx (digital therapeutics) for three or more psychiatric disorders over the next three years and obtain approval from the Ministry of Food and Drug Safety. We are looking for people who will innovate healthcare with outstanding colleagues.

WELT (웰트)

WELT (웰트)